In models of MASLD induced by hyperhomocysteinemia, CAST reduction was associated with increased calpain activity, which resulted in the degradation of the inhibitor kappa B alpha (IκBα). Here, NFKBIA is linked to metabolic dysfunction-associated steatotic liver disease.